Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Variceal Bleed Prophylaxis in Biliary Atresia
NCT04494763Unknown
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Aug 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of propranolol in Portal Hypertension (PH), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Bleeding free survival at 18 months. Status: unknown.
02
Drugs
propranolol
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT04494763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04494763.